Development and Validation of a Robust RP-HPLC Method for the Estimation of Remogliflozin Etabonate in Bulk and Tablet Dosage Forms

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Validated RP-HPLC method quantifies remogliflozin etabonate in pharmaceuticals, indicating robust quality control.

The method demonstrates excellent linearity with an R² of 0.999 and a retention time of 2.55 min, ensuring accurate quantification.
Precision results indicated %RSD values below 2%, affirming the method’s reliability for routine testing in quality control.
The study followed ICH Q2(R1) guidelines for validation and established LOD and LOQ at 0.22 µg/mL and 0.68 µg/mL, respectively.
This robust RP-HPLC method can reliably assess remogliflozin etabonate in bulk and pharmaceutical forms, enhancing routine analysis efficiency.

Surywanshi et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark